Fusion Genomics

Developing a cheaper, faster, more sensitive, single diagnostic NGS test for all infectious diseases

Fusion Genomics is advancing molecular diagnostics by developing highly sensitive and massively multiplex DNA/RNA sequencing based tests to identify infectious diseases. Using their ONETestTM platform, Fusion offers a 12 hour solution for next generation sequencing based diagnostic testing of infectious diseases providing comprehensive data analysis. The platform comprises Fusion’s proprietary UNIPrepTM, QUANTUMProbesTM and the FUSIONCloudTM with 1000x sensitivity over PCR and enhanced target enrichment. Fusion’s tests have applications from personalized medicine, pathogenomic sequencing to environmental DNA detection such as waste water surveillance.